View Older Stories View More Recent Stories

Apr 14, 2020 04:05PM Fluidigm Provides Update on COVID-19 Impact and Preliminary Revenue Estimate for First Quarter 2020
Jan 31, 2019 08:30AM Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1
Jan 14, 2019 04:05PM Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results
Jan 8, 2019 08:30AM Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring
Nov 12, 2018 04:05PM Fluidigm to Participate in the 30th Annual Piper Jaffray Healthcare Conference
Nov 9, 2018 04:05PM Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 8, 2018 08:30AM Fluidigm Showcases Immuno-Oncology Innovations for Translational and Clinical Research at SITC 2018
Nov 7, 2018 04:11PM Fluidigm Recognized as a Company to Watch in 2019
Nov 1, 2018 04:05PM Fluidigm Announces Third Quarter 2018 Financial Results
Nov 1, 2018 08:30AM Sirona Dx Introduces Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development
Oct 31, 2018 08:32AM Fluidigm (FLDM) Appoints Laura Clague to Board
Oct 31, 2018 08:30AM Laura Clague Named to Fluidigm Board of Directors
Oct 25, 2018 08:30AM Foundational 10,000 Immunomes Project Uses Mass Cytometry to Establish a Reference Standard for the Human Immune System
Oct 4, 2018 08:30AM Fluidigm Announces Agreement with DNA Software to Offer Secondary CNV Analysis for Biomark HD
Oct 1, 2018 04:15PM Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results
Sep 27, 2018 04:05PM Fluidigm Introduces Single-Cell Total RNA Sequencing Applications for C1
Sep 10, 2018 08:33AM Fluidigm (FLDM) Reports Co-Marketing Agreement with Visiopharm to Expand and Simplify Imaging Mass Cytometry Data Analysis
Sep 10, 2018 08:30AM Fluidigm Announces Co-Marketing Agreement with Visiopharm to Expand and Simplify Imaging Mass Cytometry Data Analysis
Sep 7, 2018 07:30AM Fluidigm Partners with GenomOncology to Provide a Comprehensive Immuno-Oncology Gene Expression Solution on Biomark HD
Sep 5, 2018 06:00PM Fluidigm to Participate at Upcoming Investor Events in September
Aug 9, 2018 08:30AM Fluidigm to Host 2nd Annual Imaging Mass Cytometry User Group Meeting
Aug 6, 2018 04:05PM Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 2, 2018 04:05PM Fluidigm Announces Second Quarter 2018 Financial Results
Jul 31, 2018 08:30AM Fluidigm Introduces a Lower-Cost Workflow for Full-Length Single-Cell mRNA Sequencing on C1
Jul 10, 2018 08:30AM Fluidigm Announces First Multimodal Single-Cell Application for the C1
Jul 5, 2018 04:05PM Fluidigm Announces Conference Call and Webcast of Second Quarter 2018 Financial Results
Jun 26, 2018 08:30AM David King Joins Fluidigm as Vice President, Research and Development, Genomics
Jun 7, 2018 07:00AM Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service
Jun 5, 2018 06:30AM Fluidigm Releases Sample Identification Genotyping Panel for Translational and Clinical Research
May 10, 2018 07:02PM Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 9, 2018 04:05PM Fluidigm to Participate in Upcoming Investor Events
May 3, 2018 04:04PM Fluidigm Announces First Quarter Financial Results and Operational Progress
Apr 23, 2018 08:00AM Brad Kreger Joins Fluidigm as Senior Vice President, Global Operations
Apr 19, 2018 04:05PM Fluidigm to Report Q1 2018 Financial Results and Host Conference Call
Apr 13, 2018 04:10PM Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research
Apr 12, 2018 09:29AM Fluidigm Releases CFTR Next-Generation Sequencing Library Prep Assay for Use With the Juno System
Feb 8, 2018 04:05PM Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress
Jan 25, 2018 04:05PM Fluidigm to Report Q4 and Full Year 2017 Financial Results
Dec 21, 2017 04:05PM Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 2, 2017 04:05PM Fluidigm Announces Third Quarter Financial Results and Operational Progress
Oct 24, 2017 08:10AM Fluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis
Oct 24, 2017 08:00AM Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues
Oct 19, 2017 04:05PM Fluidigm to Report Q3 2017 Financial Results and Host Conference Call
Oct 18, 2017 09:00AM Fluidigm to Unveil High-Parameter Tissue Imaging System
Aug 17, 2017 04:05PM Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System
Aug 3, 2017 04:05PM Fluidigm Announces Second Quarter Financial Results and Operational Progress
Aug 2, 2017 06:00AM Fluidigm Corporation Announces Termination of Tax Benefit Preservation Plan
Jul 27, 2017 04:05PM Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China
Jul 20, 2017 04:05PM Fluidigm to Report Q2 2017 Financial Results and Host Conference Call
Jul 18, 2017 09:02AM Fluidigm (FLDM) Announces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research
View More Recent Stories View Older Stories